Status:
RECRUITING
Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients
Lead Sponsor:
ResMed
Conditions:
OSA
Eligibility:
All Genders
18-80 years
Brief Summary
The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-y...
Eligibility Criteria
Inclusion
- Patient already included in the SunSAS study (No. ID/RCB: 2021-A01827-34) or Patient who has undergone polygraphy or polysomnography eligible for treatment with CPAP or MAD in the context of OSA.
- Patient with a sleep test performed with the Sunrise device
- Men or Women from 18 to 80 years old
- Patient with OSAS eligible for CPAP or MAD therapy
- Affiliated patient or beneficiary of a social security scheme
- Signed informed consent
Exclusion
- Patient previously treated for OSAS by CPAP or MAD during the last five years
- Patient with COPD or other respiratory diseases.
- Patient with contraindications to PPC or MAD therapy
- Patient with unstable heart disease or New York Heart Association class III or IV heart failure
- Patient unable to complete the study
Key Trial Info
Start Date :
July 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05435794
Start Date
July 15 2022
End Date
October 15 2026
Last Update
May 21 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France, 49933
2
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, France, 38043
3
CHU Lyon - Hôpital de la Croix-Rousse
Lyon, France, 69004
4
Hopital Europeen Marseille
Marseille, France, 13003